SMi's 13th annual Controlled Release conference will provide the ideal platform to receive updates on the latest innovations to accelerate commercialisation, as well as developments in the regulatory landscape to ensure strict compliance. The two-day programme is packed with unmissable case studies provided by global pharmaceutical companies including GlaxoSmithKline, MHRA, Ipsen, Novo Nordisk, MedImmune, AstraZeneca, Lundbeck, Merck, UCB Pharma, Critical Pharmaceuticals, Kashiv Pharma, Diurnal and more.